AA
ARKG icon

Ancora Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Ancora Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.1K Hold
431
– – ﹤0.01% 1340
2026
Q1 		$11.4K Buy
431
+396
+1,131% +$11.6K ﹤0.01% 1742
2025
Q4 		$1.03K Hold
35
– – ﹤0.01% 2233
2025
Q3 		$986 Hold
35
– – ﹤0.01% 1772
2025
Q2 		$864 Hold
35
– – ﹤0.01% 1766
2025
Q1 		$737 Sell
35
-36
-51% -$904 ﹤0.01% 1618
2024
Q4 		$1.67K Sell
71
-411
-85% -$10.1K ﹤0.01% 1583
2024
Q3 		$12.3K Sell
482
-10
-2% -$255 ﹤0.01% 1289
2024
Q2 		$11.6K Buy
492
+373
+313% +$9.41K ﹤0.01% 1273
2024
Q1 		$3.42K Sell
119
-8,686
-99% -$261K ﹤0.01% 1495
2023
Q4 		$289K Sell
8,805
-102
-1% -$2.77K 0.01% 606
2023
Q3 		$248K Buy
8,907
+31
+0.3% +$1.01K 0.01% 621
2023
Q2 		$303K Sell
8,876
-407
-4% -$12.8K 0.01% 564
2023
Q1 		$279K Buy
9,283
+39
+0.4% +$1.21K 0.01% 588
2022
Q4 		$261K Buy
9,244
+165
+2% +$5.24K 0.01% 619
2022
Q3 		$298K Sell
9,079
-198
-2% -$7.27K 0.01% 631
2022
Q2 		$292K Buy
9,277
+741
+9% +$25.9K 0.01% 661
2022
Q1 		$392K Sell
8,536
-3,869
-31% -$184K 0.01% 607
2021
Q4 		$760K Sell
12,405
-9,482
-43% -$656K 0.02% 447
2021
Q3 		$1.64M Buy
21,887
+40
+0.2% +$3.36K 0.04% 302
2021
Q2 		$2.02M Buy
21,847
+5,005
+30% +$426K 0.05% 274
2021
Q1 		$1.49M Buy
16,842
+7,873
+88% +$781K 0.04% 306
2020
Q4 		$836K Buy
8,969
+8,885
+10,577% +$708K 0.03% 389
2020
Q3 		$5K Buy
84
+59
+236% +$3.46K ﹤0.01% 1227
2020
Q2 		$1K Buy
+25
New +$1.07K ﹤0.01% 1295

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Ancora Advisors's ARKG Position: Q2 2026 in Review

Ancora Advisors held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 431 shares worth $18.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1340.

Ancora Advisors first reported a position in ARKG in Q2 2020 and has held it in 25 quarters since. The position peaked at $2.02M in Q2 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Ancora Advisors held 431 shares of ARK Genomic Revolution ETF worth $18.1K as of Q2 2026.
  • Ancora Advisors left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #1340 holding.
  • Ancora Advisors first reported a position in ARK Genomic Revolution ETF in Q2 2020 and has held it in 25 quarters since.
  • Ancora Advisors's ARK Genomic Revolution ETF position peaked at $2.02M in Q2 2021.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.